These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6689662)

  • 21. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence.
    Wiegand J; Hasenclever D; Tillmann HL
    Antivir Ther; 2008; 13(2):211-20. PubMed ID: 18505172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug evaluation: LB-80380--a novel phosphonate nucleoside for the potential treatment of HBV infection.
    Papatheodoridis GV; Manolakopoulos S
    Curr Opin Mol Ther; 2006 Aug; 8(4):352-7. PubMed ID: 16955699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1/hepatitis B coinfection.
    Benhamou Y
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):229-39. PubMed ID: 15918780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
    Durantel D; Alotte C; Zoulim F
    Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A call for attention and trials on hepatitis B e antigen-negative, alanine aminotransferase-normal chronic hepatitis B virus infection.
    Zhao H; Miao R
    Hepatology; 2009 Aug; 50(2):658; author reply 658-9. PubMed ID: 19585650
    [No Abstract]   [Full Text] [Related]  

  • 26. Novel hepatitis C drugs in current trials.
    Kronenberger B; Welsch C; Forestier N; Zeuzem S
    Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral antivirals for chronic hepatitis B.
    Min AD; Dienstag JL
    Clin Liver Dis; 2007 Nov; 11(4):851-68, ix. PubMed ID: 17981232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gilead sciences announces statistically significant antiviral activity against hepatitis B virus.
    AIDS Patient Care STDS; 1996 Dec; 10(6):384. PubMed ID: 11361577
    [No Abstract]   [Full Text] [Related]  

  • 29. In vitro models for studying hepatitis B virus drug resistance.
    Zoulim F
    Semin Liver Dis; 2006 May; 26(2):171-80. PubMed ID: 16673295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent research in HIV infection, part 2.
    Boyle BA
    AIDS Read; 2002 Dec; 12(12):524-6, 539. PubMed ID: 12518718
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
    Taéron C
    Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
    [No Abstract]   [Full Text] [Related]  

  • 32. [Highlights in hepatology].
    Pache I; Moradpour D
    Rev Med Suisse; 2008 Jan; 4(141):214, 216, 218-20. PubMed ID: 18335886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
    Kumar M; Sarin SK
    Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):465-95. PubMed ID: 19072396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral therapy of chronic hepatitis B.
    Zoulim F
    Antiviral Res; 2006 Sep; 71(2-3):206-15. PubMed ID: 16716414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [What's new in the treatment of hepatitis B infection?].
    Bihl F; Alaei M; Girardin M; Negro F
    Rev Med Suisse; 2009 Sep; 5(215):1720-2, 1724. PubMed ID: 19803224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial toxicity--new adverse drug effects.
    Swartz MN
    N Engl J Med; 1995 Oct; 333(17):1146-8. PubMed ID: 7565955
    [No Abstract]   [Full Text] [Related]  

  • 37. Tenofovir alafenamide (Vemlidy) for hepatitis B.
    Med Lett Drugs Ther; 2017 Jan; 59(1511):6-8. PubMed ID: 28026836
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy noncompliance in chronic viral hepatitis--standard therapy, prognostic parameters, treatment strategy].
    Hopf U
    Praxis (Bern 1994); 1997 Jan; 86(4):83-5. PubMed ID: 9064723
    [No Abstract]   [Full Text] [Related]  

  • 39. Apparent cure of hepatitis C virus carrier state after hepatitis B virus superinfection.
    Yoshinaga S; Fukushima S; Masaki N; Hayashi S
    Jpn J Infect Dis; 1999 Oct; 52(5):220. PubMed ID: 10680091
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of hepatitis B: who, when, and how?
    Wong SN; Lok AS
    Arch Intern Med; 2006 Jan; 166(1):9-12. PubMed ID: 16401805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.